Concepedia

Aurobind Vidyarthi

AV

11

Publications

654

Citations

11

H-Index

2014

Active since

Affiliations

Institute of Microbial Technology(Current)

Yale University

Council of Scientific and Industrial Research

Post Graduate Institute of Medical Education and Research

Aurobind Vidyarthi is an author at Institute of Microbial Technology specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2014–2024

11

Publications

11

TLR-3 Stimulation Skews M2 Macrophages to M1 Through IFN-αβ Signaling and Restricts Tumor Progression

Aurobind Vidyarthi, Nargis Khan, Tapan Agnihotri et al. · Frontiers in Immunology · 2018 · 151 citations · Full text

Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis

Nargis Khan, Aurobind Vidyarthi, Sajid Nadeem et al. · Frontiers in Immunology · 2016 · 148 citations · Full text

Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity

Aurobind Vidyarthi, Tapan Agnihotri, Nargis Khan et al. · Cancer Immunology Immunotherapy · 2019 · 135 citations · Full text

, , +14

Signaling through NOD-2 and TLR-4 Bolsters the T cell Priming Capability of Dendritic cells by Inducing Autophagy

Nargis Khan, Aurobind Vidyarthi, Susanta Pahari et al. · Scientific Reports · 2016 · 49 citations · Full text

NOD-2 and TLR-4 Signaling Reinforces the Efficacy of Dendritic Cells and Reduces the Dose of TB Drugs against <b><i>Mycobacterium tuberculosis</i></b>

Nargis Khan, Susanta Pahari, Aurobind Vidyarthi et al. · Journal of Innate Immunity · 2015 · 35 citations · Full text

, , +19

Rows per page

1–5 of 11